TY - JOUR
T1 - The genetic and environmental determinants of the association between brain abnormalities and schizophrenia
T2 - The schizophrenia twins and relatives consortium
AU - Van Haren, Neeltje E.M.
AU - Rijsdijk, Fruhling
AU - Schnack, Hugo G.
AU - Picchioni, Marco M.
AU - Toulopoulou, Timothea
AU - Weisbrod, Matthias
AU - Sauer, Heinrich
AU - Van Erp, Theo G.
AU - Cannon, Tyrone D.
AU - Huttunen, Matti O.
AU - Boomsma, Dorret I.
AU - Hulshoff Pol, Hilleke E.
AU - Murray, Robin M.
AU - Kahn, Rene S.
N1 - Funding Information:
Part of this study was funded by a National Alliance for Research on Schizophrenia and Depression Young Investigators Award (2004) to FR and a grant from the Dutch Brain Foundation ( 2004, 12.F04.11 ) awarded to RSK and a National Institutes of Health Grant MH52857 awarded to TDC. Part of the study in London was funded by a Wellcome Trust Research Training Fellowship ( 064971 ). The collection of the data in Germany was supported by the German Research Organization.
Funding Information:
Dr. van Haren has received honoraria for education programs for AstraZeneca, Eli Lilly, and Janssen-Cilag. Dr. Weisbrod reports having received lecture fees from SCHUHFRIED GmbH, Austria. Dr. Cannon reports that, in the past 3 years, he has served as a consultant to Rules-Based Medicine on serum-based biomarker tests for schizophrenia. Dr. Hulshoff Pol has received honoraria for education programs for Ferris and Lundbeck. Dr. Kahn has received grants and honoraria for education programs or served as consultant for AstraZeneca , Bristal-Myers Squibb , Eli Lilly , Janssen-Cilag , Otsuka , and Roche . Dr. Picchioni has received travel and educational awards from Pfizer, Janssen-Cilag, and Eli Lily. Dr. Boomsma received a precompetitive grant from Pfizer . Dr. Murray has received honoraria for educational activities from Bristal-Myers Squibb, Janssen, A-Z, Lilly, Novartis, and Otsuka. All other authors report no biomedical financial interests or potential conflicts of interest.
PY - 2012/5/15
Y1 - 2012/5/15
N2 - Background: Structural brain abnormalities are consistently found in schizophrenia (Sz) and have been associated with the familial risk for the disorder. We aim to define the relative contributions of genetic and nongenetic factors to the association between structural brain abnormalities and Sz in a uniquely powered cohort (Schizophrenia Twins and Relatives consortium). Methods: An international multicenter magnetic resonance imaging collaboration was set up to pool magnetic resonance imaging scans from twin pairs in Utrecht (The Netherlands), Helsinki (Finland), London (United Kingdom), and Jena (Germany). A sample of 684 subjects took part, consisting of monozygotic twins (n = 410, with 51 patients from concordant and 52 from discordant pairs) and dizygotic twins (n = 274, with 39 patients from discordant pairs). The additive genetic, common, and unique environmental contributions to the association between brain volumes and risk for Sz were estimated by structural equation modeling. Results: The heritabilities of most brain volumes were significant and ranged between 52% (temporal cortical gray matter) and 76% (cerebrum). Heritability of cerebral gray matter did not reach significance (34%). Significant phenotypic correlations were found between Sz and reduced volumes of the cerebrum (-.22 [-.30/-.14]) and white matter (-.17 [-.25/-.09]) and increased volume of the third ventricle (.18 [.08/.28]). These were predominantly due to overlapping genetic effects (77%, 94%, and 83%, respectively). Conclusions: Some of the genes that transmit the risk for Sz also influence cerebral (white matter) volume.
AB - Background: Structural brain abnormalities are consistently found in schizophrenia (Sz) and have been associated with the familial risk for the disorder. We aim to define the relative contributions of genetic and nongenetic factors to the association between structural brain abnormalities and Sz in a uniquely powered cohort (Schizophrenia Twins and Relatives consortium). Methods: An international multicenter magnetic resonance imaging collaboration was set up to pool magnetic resonance imaging scans from twin pairs in Utrecht (The Netherlands), Helsinki (Finland), London (United Kingdom), and Jena (Germany). A sample of 684 subjects took part, consisting of monozygotic twins (n = 410, with 51 patients from concordant and 52 from discordant pairs) and dizygotic twins (n = 274, with 39 patients from discordant pairs). The additive genetic, common, and unique environmental contributions to the association between brain volumes and risk for Sz were estimated by structural equation modeling. Results: The heritabilities of most brain volumes were significant and ranged between 52% (temporal cortical gray matter) and 76% (cerebrum). Heritability of cerebral gray matter did not reach significance (34%). Significant phenotypic correlations were found between Sz and reduced volumes of the cerebrum (-.22 [-.30/-.14]) and white matter (-.17 [-.25/-.09]) and increased volume of the third ventricle (.18 [.08/.28]). These were predominantly due to overlapping genetic effects (77%, 94%, and 83%, respectively). Conclusions: Some of the genes that transmit the risk for Sz also influence cerebral (white matter) volume.
KW - Brain volumes
KW - multicenter
KW - phenotypic correlation
KW - sMRI
KW - schizophrenia
KW - twins
UR - http://www.scopus.com/inward/record.url?scp=84860159631&partnerID=8YFLogxK
U2 - 10.1016/j.biopsych.2012.01.010
DO - 10.1016/j.biopsych.2012.01.010
M3 - Article
C2 - 22341827
AN - SCOPUS:84860159631
SN - 0006-3223
VL - 71
SP - 915
EP - 921
JO - Biological Psychiatry
JF - Biological Psychiatry
IS - 10
ER -